These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 868543)
41. Polysubstituted pyrazoles. Part 2: Sulphonamidophenylhydrazone-2-pyrazolin-4-ones and sulphonamidophenylazopyrazoles as potential anticancer agents. Soliman FS; Shafik RM Pharmazie; 1975 Jul; 30(7):436-9. PubMed ID: 1178757 [TBL] [Abstract][Full Text] [Related]
42. [Tetrafluorosuccinic anhydride, a new reagent for the specific and reversible masking of amino groups in proteins]. Braunitzer G; Beyreuther K; Fujiki H; Schrank B Hoppe Seylers Z Physiol Chem; 1968 Feb; 349(2):265. PubMed ID: 5677013 [No Abstract] [Full Text] [Related]
43. Solid-phase synthesis of 5-substituted amino pyrazoles. Dodd DS; Martinez RL; Kamau M; Ruan Z; Van Kirk K; Cooper CB; Hermsmeier MA; Traeger SC; Poss MA J Comb Chem; 2005; 7(4):584-8. PubMed ID: 16004502 [TBL] [Abstract][Full Text] [Related]
44. VI.2 The confirmation of low levels of volatile nitrosamines by oxidation to nitramines. Sen NP; Fiddler W; Webb KS IARC Sci Publ; 1983; (45):499-503. PubMed ID: 6618630 [No Abstract] [Full Text] [Related]
45. [The preparation of some derivatives of 5-methylindazole-3-carboxylic acid]. Hannig E; Kollmorgen C; Geipel I Pharmazie; 1973; 28(11):720-3. PubMed ID: 4791253 [No Abstract] [Full Text] [Related]
46. 1-N-substituted thiocarbamoyl-3-phenyl-5-thienyl-2-pyrazolines: synthesis and evaluation as MAO inhibitors. Gökhan N; Yeşilada A; Uçar G; Erol K; Bilgin AA Arch Pharm (Weinheim); 2003 Aug; 336(8):362-71. PubMed ID: 14502756 [TBL] [Abstract][Full Text] [Related]
47. Letter: On the reaction of ethyl 4,4,4-trifluoroacetoacetate with cyanoacetic acid hydrazide--a novel rearrangement of 1-aminopyridine derivatives. Balicki R; Nantka-Namirski P Acta Pol Pharm; 1975; 32(1):129-31. PubMed ID: 1114907 [No Abstract] [Full Text] [Related]
49. [Pyrazolidinediones. III. O-Acetyl and N-acetyl derivatives. Synthesis and structural study]. Chraibi A; Luu-Duc C; Chantegrel J Ann Pharm Fr; 1983; 41(1):45-53. PubMed ID: 6625477 [No Abstract] [Full Text] [Related]
50. [Preparation of compounds with amidino- or amidoxime structures]. Fokken B; Woossmann D; Bräuniger H; Peseke K; Kristen H Pharmazie; 1977 Oct; 32(10):566-9. PubMed ID: 607212 [No Abstract] [Full Text] [Related]
51. Laboratory decontamination and destruction of carcinogens in laboratory wastes: some aromatic amines and 4-nitrobiphenyl. Castegnaro M; Barek J; Dennis J; Ellen G; Klibanov M; Lafontaine M; Mitchum R; Van Roosmalen P; Sansone EB; Sternson LA IARC Sci Publ; 1985; (64):1-85. PubMed ID: 4065953 [No Abstract] [Full Text] [Related]
52. [Studies on pyrazole derivatives. IV. Synthesis and studies of 6H, 7H-pyrazolo-(3,2-b)-thiazole-1,2,4 derivatives]. Dymek W; Ryznerski Z Acta Pol Pharm; 1968; 25(4):375-82. PubMed ID: 5670539 [No Abstract] [Full Text] [Related]
53. Synthesis and antimicrobial activity of some new pyrazole derivatives containing a ferrocene unit. Damljanović I; Vukićević M; Radulović N; Palić R; Ellmerer E; Ratković Z; Joksović MD; Vukićević RD Bioorg Med Chem Lett; 2009 Feb; 19(4):1093-6. PubMed ID: 19167220 [TBL] [Abstract][Full Text] [Related]
54. Facile access to pyrazolines via domino reaction of the Huisgen zwitterions with aziridines. Cui SL; Wang J; Wang YG Org Lett; 2008 Jan; 10(1):13-6. PubMed ID: 18062691 [TBL] [Abstract][Full Text] [Related]
55. [Reactions of 4-ethoxycarbonyl-3-amino-2-aminocarbonyl-5-methylthiopyrazole with isocyanates or isothiocyanates]. Werbs H; Peseke K; Bräuniger H Pharmazie; 1974; 29(10-11):687-9. PubMed ID: 4438409 [No Abstract] [Full Text] [Related]
56. 4-(1H-pyrazol-1-yl)-2-butylamine derivatives as inhibitors of blood platelet aggregation. Ferroni R; Milani L; Simoni D; Orlandini P; Guarneri M; Franzé D; Bardi A Farmaco; 1989 May; 44(5):495-502. PubMed ID: 2506876 [TBL] [Abstract][Full Text] [Related]
57. 3,5-Diphenyl-1H-pyrazole derivatives. VI--Esters and 2-dialkylaminoethyl ethers of 1(2-hydroxy-2-phenylethyl)-3,5-diphenyl-1H-pyrazole and N,N-disubstituted 1-(2-amino-2-phenylethyl)-3,5-diphenyl-1H-pyrazoles with depressant and platelet antiaggregating activities. Bondavalli F; Bruno O; Ranise A; Schenone P; Losasso C; Stella L; de Paola C; Ioia N; Marmo E Farmaco; 1990 May; 45(5):511-26. PubMed ID: 2222723 [TBL] [Abstract][Full Text] [Related]
58. Synthesis of and pharmacological studies on the antidepressant and anticonvulsant activities of some 1,3,5-trisubstituted pyrazolines. Ruhoğlu O; Ozdemir Z; Caliş U; Gümüşel B; Bilgin AA Arzneimittelforschung; 2005; 55(8):431-6. PubMed ID: 16149709 [TBL] [Abstract][Full Text] [Related]
59. Oxaziridine-mediated amination of primary amines: scope and application to a one-pot pyrazole synthesis. Armstrong A; Jones LH; Knight JD; Kelsey RD Org Lett; 2005 Feb; 7(4):713-6. PubMed ID: 15704932 [TBL] [Abstract][Full Text] [Related]
60. [Synthesis and pharmacological properties of pyrazole compounds. II. 4-aminopyrazole derivatives variously substituted in the 1 position]. Bianchi M; Bonacina F; Osvaldo A; Pirola C Farmaco Sci; 1970 Aug; 25(8):592-617. PubMed ID: 5491604 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]